Virani SS, Alonso A, et al. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143:e254–743.

Article  PubMed  Google Scholar 

Conrad N, Judge A, Canoy D, Tran J, Pinho-Gomes AC, Millett ERC, Salimi-Khorshidi G, Cleland JG, McMurray JJV, Rahimi K. Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86 000 individuals. JAMA Cardiol. 2019;4:1102–11.

Article  PubMed  PubMed Central  Google Scholar 

Bittira B, Shum-Tim D, Al-Khaldi A, Chiu RCJ. Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg. 2003;24:393–8.

Article  PubMed  Google Scholar 

Tse H-F, Kwong Y-L, Chan JKF, Lo G, Ho C-L, Lau C-P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361:47–9.

Article  PubMed  Google Scholar 

Porat Y, Porozov S, Belkin D, et al. Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages. Br J Haematol. 2006;135:703–14.

Article  CAS  PubMed  Google Scholar 

Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428:668–73.

Article  CAS  PubMed  Google Scholar 

Razeghian-Jahromi I, Matta AG, Canitrot R, Zibaeenezhad MJ, Razmkhah M, Safari A, Nader V, Roncalli J. Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy. Stem Cell Res Ther. 2021;12:361.

Article  PubMed  PubMed Central  Google Scholar 

Al-Khalaf HH, Al-Harbi B, Al-Sayed A, Arafah M, Tulbah A, Jarman A, Al-Mohanna F, Aboussekhra A. Interleukin-8 activates breast cancer-associated adipocytes and promotes their angiogenesis- and tumorigenesis-promoting effects. Mol Cell Biol. 2019;39:e00332-e418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Z, Wu J, Fujii H, et al. Human angiogenic cell precursors restore function in the infarcted rat heart: a comparison of cell delivery routes. Eur J Heart Fail. 2008;10:525–33.

Article  CAS  PubMed  Google Scholar 

Arom KV, Ruengsakulrach P, Jotisakulratana V. Intramyocardial angiogenic cell precursor injection for cardiomyopathy. Asian Cardiovasc Thorac Ann. 2008;16:143–8.

Article  PubMed  Google Scholar 

Williams AR, Trachtenberg B, Velazquez D, et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy functional recovery and reverse remodeling. Circ Res. 2011;108:792–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaithiraphan S, Dutsadeevettakul S, Tasneeyapant S, et al. Transcoronary injection of angiogenic cells precursors in autologous stem CELL IN ischemic cardiomyopathy: a clinical study of 106 cases in Thailand. Asean Heart Journal. 2009;17:13–22.

Google Scholar 

Traverse JH, Henry TD, Ellis SG, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011;306:2110–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perin EC, Willerson JT, Pepine CJ, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012;307:1717–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choudry F, Hamshere S, Saunders N, et al. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial. Eur Heart J. 2016;37:256–63.

Article  PubMed  Google Scholar 

Martino H, Brofman P, Greco O, et al. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study). Eur Heart J. 2015;36:2898–904.

Article  PubMed  Google Scholar 

Henry TD, Pepine CJ, Lambert CR, et al. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017;89:169–77.

Article  PubMed  Google Scholar 

Florea V, Rieger AC, DiFede DL, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ Res. 2017;121:1279–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leistner DM, Fischer-Rasokat U, Honold J, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol. 2011;100:925–34.

Article  PubMed  Google Scholar 

Bolli R, Solankhi M, Tang XL, Kahlon A. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res. 2022;118:951–76.

Article  CAS  PubMed  Google Scholar 

Vrtovec B, Poglajen G, Lezaic L, et al. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy. Circulation. 2013;128:42–9.

Article  Google Scholar 

Banovic M, Poglajen G, Vrtovec B, Ristic A. Contemporary challenges of regenerative therapy in patients with ischemic and non-ischemic heart failure. J Cardiovasc Dev Dis. 2022;9:429.

CAS  PubMed  PubMed Central  Google Scholar 

Perbellini O, Cioffi F, Malpeli G, Zanolin E, Lovato O, Scarpa A, et al. Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia. Leuk Lymphoma. 2015;56:1897–900.

Article  PubMed  Google Scholar 

Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol. 2002;3:221–7. https://doi.org/10.1038/ni0302-221.

Article  CAS  PubMed  Google Scholar 

Han Z-J, Li Y-B, Yang L-X, Cheng H-J, Liu X, Chen H. Roles of the CXCL8-CXCR1/2 axis in the tumor microenvironment and Immunotherapy. Molecules. 2021;27:137.

Article  PubMed  PubMed Central  Google Scholar 

Massa M, Rosti V, Ferrario M, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005;105:199–206.

Article  CAS  PubMed  Google Scholar 

Schömig K, Busch G, Steppich B, et al. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J. 2006;27:1032–7.

Article  PubMed  Google Scholar 

Jha NK, Jha SK, Kar R, Nand P, Swati K, Goswami VK. Nuclear factor-kappa B as a therapeutic target for Alzheimer’s disease. J Neurochem. 2019;150:113–37.

Article  CAS  PubMed  Google Scholar 

Brodarac A, Šarić T, Oberwallner B, et al. Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation. Stem Cell Res Ther. 2015;6:83.

Article  PubMed  PubMed Central  Google Scholar 

Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308:2369.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burst VR, Gillis M, Pütsch F, et al. Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol. 2009;114:e107–16.

Article  PubMed  Google Scholar 

Ikebe C, Suzuki K. Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols. Biomed Res Int. 2014;2014:1–11.

Article  Google Scholar 

Mathiasen AB, Jørgensen E, Qayyum AA, Haack-Sørensen M, Ekblond A, Kastrup J. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Am Heart J. 2012;164:285–91.

Article  PubMed  Google Scholar 

Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003;17:160–70.

Article  CAS  PubMed  Google Scholar 

Chen H, Zhou L. Treatment of ischemic stroke with modified mesenchymal stem cells. Int J Med Sci. 2022;19:1155–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vrtovec B, Poglajen G, Lezaic L, et al. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res. 2013;112:165–73.

Article  CAS  PubMed  Google Scholar 

Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395–402.

Article  CAS